Sangair AB
559080-3317ActiveDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Oversigt
- 3
- Medarbejdere
- 0 SEK
- Omsætning
- 2016
- Grundlagt
Nøglebeslutningstagere
Susanne Olausson
Board Member
Johan Sjöholm
Board Member and Founder
Henrik Rundgren
Board member
Martin Wiklund
Board Member
+2 flere kontakter i Funnelfeedr
Beskrivelse
Sangair AB is a Swedish biotechnology company focused on developing innovative solutions for critical medical conditions. Their core innovation is SangAsept, a unique process designed to treat blood extracorporeally, meaning outside the body. This technology immediately targets and reduces harmful b...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Tillverkning av medicinska och dentala instrument och tillbehör
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559080331701
Beslutningstagere
6 kontakter i FunnelfeedrSusanne Olausson
Board Member
Johan Sjöholm
Board Member and Founder
Henrik Rundgren
Board member
Martin Wiklund
Board Member
Niclas Jonasson
Chairman of the Board
Andre kontakter
Sara Weman
Engineer
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrModus Therapeutics Holding AB
1–4 medarbejdereSwedish biotech developing sevuparin for severe inflammatory conditions.
Modus Therapeutics AB
Swedish biotech developing sevuparin for severe inflammatory diseases.
Gradientech AB
20–49 medarbejdereDeveloping ultra-rapid diagnostic systems for antibiotic susceptibility testing.
bioMérieux Sweden AB
20–49 medarbejdereWorld leader developing in vitro diagnostics for health and safety.
Aptahem AB
0 medarbejdereBiotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Udforsk mere
Spørgsmål om Sangair AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo